Correlation Between Sprott Focus and Santen Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Sprott Focus and Santen Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sprott Focus and Santen Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sprott Focus Trust and Santen Pharmaceutical Co, you can compare the effects of market volatilities on Sprott Focus and Santen Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sprott Focus with a short position of Santen Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sprott Focus and Santen Pharmaceutical.
Diversification Opportunities for Sprott Focus and Santen Pharmaceutical
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Sprott and Santen is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Sprott Focus Trust and Santen Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Santen Pharmaceutical and Sprott Focus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sprott Focus Trust are associated (or correlated) with Santen Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Santen Pharmaceutical has no effect on the direction of Sprott Focus i.e., Sprott Focus and Santen Pharmaceutical go up and down completely randomly.
Pair Corralation between Sprott Focus and Santen Pharmaceutical
Given the investment horizon of 90 days Sprott Focus Trust is expected to under-perform the Santen Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Sprott Focus Trust is 1.31 times less risky than Santen Pharmaceutical. The stock trades about -0.3 of its potential returns per unit of risk. The Santen Pharmaceutical Co is currently generating about -0.22 of returns per unit of risk over similar time horizon. If you would invest 1,115 in Santen Pharmaceutical Co on October 7, 2024 and sell it today you would lose (62.00) from holding Santen Pharmaceutical Co or give up 5.56% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Sprott Focus Trust vs. Santen Pharmaceutical Co
Performance |
Timeline |
Sprott Focus Trust |
Santen Pharmaceutical |
Sprott Focus and Santen Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sprott Focus and Santen Pharmaceutical
The main advantage of trading using opposite Sprott Focus and Santen Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sprott Focus position performs unexpectedly, Santen Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Santen Pharmaceutical will offset losses from the drop in Santen Pharmaceutical's long position.Sprott Focus vs. MFS Investment Grade | Sprott Focus vs. Eaton Vance National | Sprott Focus vs. Nuveen California Select | Sprott Focus vs. Federated Premier Municipal |
Santen Pharmaceutical vs. Ono Pharmaceutical Co | Santen Pharmaceutical vs. GSK plc | Santen Pharmaceutical vs. Grifols SA ADR | Santen Pharmaceutical vs. Pfizer Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |